Backed by General Catalyst and GV.
About the role
Parabilis Medicines, Inc. is seeking a hands-on, experienced Security and Compliance Senior Manager to join our lean and high-impact technology team. As a recently public company operating under SOX, GxP, HIPAA, and SOC2 frameworks, Parabilis relies on a strong security and compliance posture to protect its science, its data, and its patients. This role owns that posture in partnership with the Sr. Director of IT.
What they're looking for
- 6+ years of hands-on experience in technical security, ideally within regulated industries
- Bachelor’s degree in Computer Science, Information Systems, or related field preferred
- Demonstrated experience operating within a regulated compliance environment (FDA/GxP, HIPAA, SOX, or SOC2), ideally in life sciences, healthcare, or another audited industry
- Hands-on expertise across endpoint security (EDR/MDR), identity and access management (Okta, Entra ID), and cloud security (AWS multi-account environments)
- Practical experience implementing and operating security controls and mapping them to compliance frameworks and audit requirements
- Proven ability to lead incident response and manage security and compliance vendors and consultants to deliver outcomes
More about this role
About Parabilis Medicines
At Parabilis Medicines, we are redefining what's possible in drug discovery. We are a clinical-stage biopharmaceutical company dedicated to creating unique and extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered beyond the reach of conventional medicines. Our intent is to create an important long-lived company partnering with patients, healthcare providers, researchers, investors and strategic collaborators who share our curiosity, determination and commitment to create real-world impact.
Our proprietary Helicon™ platform has pioneered a new class of stabilized alpha-helical peptides capable of modulating intracellular proteins that have historically been considered "undruggable." Our lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin interaction that has demonstrated compelling early clinical activity across a range of Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP), adamantinomatous craniopharyngioma (ACP), hepatocellular carcinoma (HCC) and other solid tumor indications. We are also advancing...
Browse similar: Startup jobs · Remote jobs